Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03810651 · ClinicalTrials.gov registry record · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
A Early Phase 1 study of Wilms Tumor and Renal Tumor, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT03810651: Recruiting Early Phase 1 study of Wilms Tumor and Renal Tumor, sponsored by Children's Hospital of Philadelphia.
NCT03810651 is a Early Phase 1 study of Wilms Tumor and Renal Tumor that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 28 participants, below the 291-participant average among 14 other Wilms Tumor trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03810651, a Early Phase 1 study of Wilms Tumor and Renal Tumor, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.
Primary Outcome
Acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors. Acute toxicity is defined as any non-hematologic toxicity that occurs within 90 days following the start of proton therapy. NCI Common toxicity criteria (CTC Version 4.0) grades will be employed. Individual category content listings are available to investigators at http://ctep.cancer.gov, with attention to the following System Organ Classes and CTCAE Adverse Events: General Disorders and Administration
Conditions Studied
Interventions
- OTHER Proton beam radiation using pencil beam scanning
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-12-26 |
| Est. Completion | 2027-10-30 |
| Phase | Early Phase 1 |
What NCT03810651 shows while recruiting
NCT03810651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 291-participant average among 14 other Wilms Tumor trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Wilms Tumor appearing as the primary indexed condition, and to 1 intervention - of which Proton beam radiation using pencil beam scanning is the first listed.
NCT03810651 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03810651 about?
NCT03810651 is a clinical study titled "Pencil Beam Scanning in Patients With Renal Tumors". This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.
What is the current status of trial NCT03810651?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2017-12-26. Estimated completion is 2027-10-30.
What conditions does trial NCT03810651 study?
This clinical trial studies the following conditions: Wilms Tumor, Renal Tumor.
What interventions are being tested in trial NCT03810651?
The interventions under investigation include: Proton beam radiation using pencil beam scanning (OTHER).
Who is sponsoring clinical trial NCT03810651?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03810651 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wilms Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03810651's enrollment target sits among peer trials
28 8th of 14 higher than 7 of 14 other Wilms Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wilms Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
International PPB/DICER1 Registry
RECRUITING
-
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RECRUITING · Phase 1
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
RECRUITING · Phase 1
-
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
RECRUITING · Phase 1
-
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03842943 · 28 participants · Phase 2
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI